Call for Session, Presentation, Workshop, and Short Course Abstracts
Read Abstract Details | Submit
Abstract Submission Deadline: Wednesday, April 30
Notification: Week of June 30
Final PowerPoint Presentations Due: October 6
Meeting Dates: October 27-28, 2025
Location: QUEBEC, CANADA
Questions: Contact Lynda.Fisher@DIAglobal.org
Are you a professional involved in the regulatory, clinical or safety and pharmacovigilance functional areas within a company or organization working on pharmaceuticals, drugs, medical devices, and/or diagnostics in Canada? If so, DIA wants to hear from you!
To ensure that we have the most comprehensive and cutting-edge program, we are seeking abstract submissions from professionals like yourself, who are pushing the boundaries in their respective fields. We encourage you to submit abstracts that reflect the latest trends, innovations, and best practices in regulatory, clinical or safety and pharmacovigilance in Canada. We will be accepting the following formats:
- Presentations: 15-20-minute presentation to be bundled with other presentations to create a session
- Sessions: 60-75-minute total session
- Workshop: 60-minute workshop delivered in an interactive/simulation or role-playing format
- Short Courses: three-hour interactive workshop delivered in a small group format (these will be delivered virtually and require a separate fee from attendees)
The Canada Annual Meeting Program Committee is seeking abstracts on the following topics (keep in mind, business use cases and lessons learned are encouraged in all topic areas). Please note that this meeting is attended by many regulatory, clinical and safety professionals, service providers, and health authority representatives, and therefore, topics in addition to those listed below, that you feel are relevant, may be submitted for evaluation and possible selection.
Regulatory Track:
- The regulatory track provides opportunities for information sharing, use cases, and best practices relating to Canada’s regulatory landscape as it applies to regulatory requirements, new developments, and innovation for life sciences R&D.
Clinical Track:
- Today, modern pharmaceuticals, drugs, medical devices, and diagnostic products are advancing at an unprecedented speed. Sessions in this track will focus on clinical research development and operations for industry.
Safety and Pharmacovigilance Track:
- Our safety and pharmacovigilance track will provide a comprehensive overview of Canada’s regulatory environment in the field of clinical safety and pharmacovigilance for pharmaceutical products, drugs, medical devices, and diagnostics.
Abstract Details and Guidelines
